Meddenovo Drug Design
AI-driven drug development
- B2B
- AI-native
About Meddenovo Drug Design
A company specializing in AI technology and molecular modeling for drug development, offering unique solutions for drug candidate optimization and custom computational services
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Lyon, Auvergne-Rhône-Alpes, France
- Founded
- 2023
- Revenue
- $4.4M – $34.4MTamtam estimate
- Website
- meddenovo.com
Meddenovo Drug Design at a glance
Meddenovo Drug Design is a B2B company in the Biotechnology Research industry, headquartered in Lyon, Auvergne-Rhône-Alpes, France.
Meddenovo Drug Design was founded in 2023.
Meddenovo Drug Design has 1–10 employees.
Meddenovo Drug Design's revenue is $4.4M – $34.4M (Tamtam estimate).
Selling to companies like Meddenovo Drug Design?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies